HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment.

Abstract
Chemokines are thought to contribute to the cellular infiltrate characteristic of renal transplant rejection. We show that Met-RANTES, a chemokine receptor antagonist, suppresses recruitment of inflammatory cells into renal allografts. In a renal transplant model (Fisher RT1(lvl) rat kidney into Lewis RT1(l) rat) where no additional immune suppressant was used, Met-RANTES-treated animals showed a significant reduction in vascular injury score (16.10 +/- 5.20 vs. 62.67 +/- 18.64) and tubular damage score (15.70 +/- 5.22 vs. 33.00 +/- 6.44) relative to untreated animals. In a more severe rejection model (Brown-Norway RT1(n) rat kidney into Lewis RT1(1) rat), Met-RANTES significantly augmented low-dose cyclosporin A treatment to reduce all aspects of renal injury including interstitial inflammation (score 71.00 +/- 6.10 vs. 157.30 +/- 21.30). The majority of infiltrating cells in these models (60-70%) consisted of monocytes. Potential mechanisms of action of Met-RANTES were tested using monocyte attachment assays on microvascular endothelium under physiological flow conditions. Preexposure of microvascular endothelium to RANTES resulted in RANTES immobilization and RANTES-induced firm adhesion of monocytes only after prestimulation of the endothelium with IL-1beta. Met-RANTES completely inhibited this RANTES-mediated arrest. Thus, Met-RANTES may counter acute rejection by blocking leukocyte firm adhesion to inflamed endothelium.
AuthorsH J Gröne, C Weber, K S Weber, E F Gröne, T Rabelink, C M Klier, T N Wells, A E Proudfood, D Schlöndorff, P J Nelson
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 13 Issue 11 Pg. 1371-83 (Aug 1999) ISSN: 0892-6638 [Print] United States
PMID10428761 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemokine CCL5
  • Immunosuppressive Agents
  • RANTES, Met-
  • Cyclosporine
Topics
  • Animals
  • Chemokine CCL5 (analogs & derivatives, immunology)
  • Cyclosporine (administration & dosage)
  • Endothelium, Vascular (immunology, pathology)
  • Graft Rejection (immunology, prevention & control)
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Kidney Transplantation
  • Kidney Tubules (immunology, pathology)
  • Male
  • Monocytes (immunology, pathology)
  • Rats
  • Rats, Inbred BN
  • Rats, Inbred F344
  • Rats, Inbred Lew
  • Transplantation Immunology
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: